Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 20Pain, Postoperative 5Stomach Neoplasms 4Pancreatic Neoplasms 4Neoplasms 4Lung Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Brain Neoplasms 4Prostatic Neoplasms 3Myoma 3Leiomyoma 3Head and Neck Neoplasms 3Glioblastoma 3Colorectal Neoplasms 3Agnosia 3Stomatitis 2Skin Neoplasms 2Postoperative Hemorrhage 2Ovarian Neoplasms 2Neoplasm Metastasis 2Melanoma 2Lymphoma, Non-Hodgkin 2Hemorrhage 2Fatigue 2Colonic Neoplasms 2Chronic Pain 2Carcinoma, Hepatocellular 2Water-Electrolyte Imbalance 1Vulvodynia 1Uterine Cervical Neoplasms 1

Interventions

Electrocardiography 3Echocardiography 3Surveys and Questionnaires 2Nutrition Assessment 2Carvedilol 2ziprasidone 1sacubitril and valsartan sodium hydrate drug combination 1candesartan 1Zolpidem 1Warfarin 1Vecuronium Bromide 1Vascular Stiffness 1Vancomycin 1Tranexamic Acid 1Tobramycin 1Spironolactone 1Sodium Chloride 1Simendan 1Sevelamer 1Rocuronium 1Resistance Training 1Pulse Wave Analysis 1Piperacillin, Tazobactam Drug Combination 1Pentobarbital 1Palliative Care 1Oxycodone 1Nifedipine 1Nafcillin 1Molindone 1Metoprolol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Heart Failure × Sodium Chloride × Clear all
NCT03557255 2018-06-14

Levosimendan for Cardiac Patients Undergoing Major Abdominal Cancer Surgeries

National Cancer Institute, Egypt

Phase 2 Completed
60 enrolled

Heart Failure

Data powered by HemOnc (CC BY 4.0) Colophon âš¡